摘要
目的探讨MRI特异性对比剂钆塞酸二钠注射液(Gd-EOB-DTPA,普美显)增强扫描对肝脏局灶性结节性增生(FNH)的诊断价值。方法选取2012年11月—2017年4月我院收治的FNH患者66例为研究对象,所选患者中采用钆塞酸二钠作为对比剂行MRI增强扫描的患者14例,采用钆喷酸葡胺(Gd-DTPA)作为对比剂行MRI增强扫描的患者52例,比较两种检测结果的特异性和灵敏性。结果 MRI钆塞酸二钠增强扫描诊断敏感性明显高于MRI钆喷酸葡胺,差异有统计学意义(P<0.05);而两组方式阳性预测值差异无统计学意义(P>0.05)。结论 MR钆塞酸二钠增强扫描能提高临床对FNH的诊断准确率,具有较高的特异性和灵敏性。
Objective To discuss the value of Gd-EOB-DTPA-enhanced MRI in diagnosis of nodular pathologic changes of liver. Methods 66 patients with FNH were enrolled in our hospital from November 2011 to April 2017. On the 66 patients, Gd-EOB-DTPA was used as contrast agent for 14 patients with enhanced MRI scan, Gadolinium DTPA （Gd-DTPA） was used as contrast agent for 52 patients with enhanced MRI scan, and the specificity and sensitivity of the two detection results were compared. Results The sensitivity of Gd-EOB-DTPA enhanced scan was higher than that of Gadolinium DTPA, the difference was statistically significant （P 〈 0.05）. The positive predictive value of the two groups was not statistically significant （P 〉 0.05）. Conclusion MRI Gd-EOB-DTPA enhanced scan can improve the accuracy of clinical diagnosis of FNH, and has high specificity and sensitivity.
出处
《中国卫生标准管理》
2017年第17期107-110,共4页
China Health Standard Management
